{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:35Z","timestamp":1772119775816,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11096-021-01257-8","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T11:02:31Z","timestamp":1615114951000},"page":"1345-1351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short and long term impact of combining restrictive and enabling interventions to reduce aztreonam consumption in a community hospital"],"prefix":"10.1007","volume":"43","author":[{"given":"Dviti","family":"Mody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-3120","authenticated-orcid":false,"given":"Quentin","family":"Minson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"1257_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016. https:\/\/doi.org\/10.1093\/cid\/ciw118.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1257_CR2","doi-asserted-by":"publisher","first-page":"CD003543","DOI":"10.1002\/14651858.CD003543.pub4","volume":"2","author":"P Davey","year":"2017","unstructured":"Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2(2):CD003543. https:\/\/doi.org\/10.1002\/14651858.CD003543.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"1257_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1086\/321880","volume":"33","author":"R Gross","year":"2001","unstructured":"Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001;33:289\u201395.","journal-title":"Clin Infect Dis"},{"key":"1257_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jac\/dkn218","volume":"62","author":"KL Buising","year":"2008","unstructured":"Buising KL, Thursky KA, Robertson MB, Black JF, Street AC, Richards MJ, et al. Electronic antibiotic stewardship\u2014reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother. 2008;62:608\u201316. https:\/\/doi.org\/10.1093\/jac\/dkn218.","journal-title":"J Antimicrob Chemother"},{"key":"1257_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mayocp.2017.09.020","volume":"93","author":"T Pongdee","year":"2018","unstructured":"Pongdee T, Li JT. Evaluation and management of penicillin allergy. Mayo Clin Proc. 2018;93:101\u20137.","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 1","key":"1257_CR6","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/ofid\/ofy343","volume":"6","author":"D Shortridge","year":"2019","unstructured":"Shortridge D, Gales AC, Streit JM, Huband MD, Tsakris A, Jones RN. Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY antimicrobial surveillance program, 1997\u20132016. Open Forum Infect Dis. 2019;6(Suppl 1):S63\u20138. https:\/\/doi.org\/10.1093\/ofid\/ofy343.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"1257_CR7","doi-asserted-by":"publisher","first-page":"322.e7-14","DOI":"10.1016\/j.jcrc.2011.09.004","volume":"27","author":"JG Muscedere","year":"2012","unstructured":"Muscedere JG, Shorr AF, Jiang X, Day A, Heyland DK, Canadian Critical Care Trials Group. The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome. J Crit Care. 2012;27(3):322.e7-14. https:\/\/doi.org\/10.1016\/j.jcrc.2011.09.004.","journal-title":"J Crit Care"},{"issue":"5","key":"1257_CR8","doi-asserted-by":"publisher","first-page":"e00010","DOI":"10.1128\/AAC.00010-19","volume":"63","author":"C Emeraud","year":"2019","unstructured":"Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, et al. Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-\u03b2-lactamase-producing gram-negative bacteria. Antimicrob Agents Chemother. 2019;63(5):e00010-19. https:\/\/doi.org\/10.1128\/AAC.00010-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"1257_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/jac\/dkz497","volume":"75","author":"OA Cornely","year":"2020","unstructured":"Cornely OA, Cisneros JM, Torre-Cisneros J, Rodr\u00edguez-Hern\u00e1ndez MJ, Tall\u00f3n-Aguilar L, Calbo E, et al. Pharmacokinetics and safety of aztreonam\/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study. J Antimicrob Chemother. 2020;75:618\u201327.","journal-title":"J Antimicrob Chemother"},{"key":"1257_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11096-016-0248-y","volume":"38","author":"SM Swearingen","year":"2016","unstructured":"Swearingen SM, White C, Weidert S, Hinds M, Narro JP, Guarascio AJ. A multidimensional antimicrobial stewardship intervention targeting aztreonam use in patients with a reported penicillin allergy. Int J Clin Pharm. 2016;38:213\u20137.","journal-title":"Int J Clin Pharm"},{"key":"1257_CR11","doi-asserted-by":"publisher","unstructured":"Phan A, Allen B, Epps K, Alikhil M, Kamataris K, Tucker C. Initiative to reduce aztreonam use in patients with self-reported penicillin allergy: effects on clinical outcomes and antibiotic prescribing patterns. Am J Health Syst Pharm. 2018;75(17 Supplement 3):S58\u201362. https:\/\/doi.org\/https:\/\/doi.org\/10.2146\/ajhp170400. (Erratum in: Am J Health Syst Pharm. 2018;75(19):1443).","DOI":"10.2146\/ajhp170400"},{"key":"1257_CR12","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2021. Oslo; 2020. ISBN 978-82-8406-165-8"},{"key":"1257_CR13","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1592\/phco.26.9.1320","volume":"26","author":"TP Lodise","year":"2006","unstructured":"Lodise TP, Lomaestro BM, Drusano GL, Society of Infectious Diseases Pharmacists. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2006;26:1320\u201332.","journal-title":"Pharmacotherapy"},{"key":"1257_CR14","unstructured":"Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data, 4th edn. Approved guideline M39-A4. Wayne, PA: Clinical and Laboratory Standards Institute; 2014. ISBN Number: 1-56238-950-5."},{"issue":"8","key":"1257_CR15","doi-asserted-by":"publisher","first-page":"e199369","DOI":"10.1001\/jamanetworkopen.2019.9369","volume":"2","author":"DJ Anderson","year":"2019","unstructured":"Anderson DJ, Watson S, Moehring RW, Komarow L, Finnemeyer M, Arias RM, et al. Feasibility of core antimicrobial stewardship interventions in community hospitals. JAMA Netw Open. 2019;2(8):e199369. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.9369.","journal-title":"JAMA Netw Open"},{"key":"1257_CR16","doi-asserted-by":"publisher","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61\u2013111. https:\/\/doi.org\/https:\/\/doi.org\/10.1093\/cid\/ciw353. (Epub 2016 Jul 14. Erratum in: Clin Infect Dis. 2017;64(9):1298. Erratum in: Clin Infect Dis. 2017;65(8):1435. Erratum in: Clin Infect Dis. 2017;65(12):2161).","DOI":"10.1093\/cid\/ciw353"},{"key":"1257_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1179\/joc.2005.17.6.622","volume":"17","author":"HS Sader","year":"2005","unstructured":"Sader HS, Rhomberg PR, Jones RN. In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii. J Chemother. 2005;17:622\u20137.","journal-title":"J Chemother"},{"key":"1257_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/511640","volume":"44","author":"RE Polk","year":"2007","unstructured":"Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664\u201370.","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-021-01257-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:53:36Z","timestamp":1744138416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-021-01257-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1007\/s11096-021-01257-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-210536\/v1","asserted-by":"object"}]},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,7]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The University of Tennessee Health Sciences Center (UTHSC) institutional review board approved this study under identification number 19-06983-XP on December 13, 2019 prior to study initiation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}